The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/capivasertib-wins-metastatic-prostate-cancer-approval-2026a1000k4n?src=rss
Author :
Publish date : 2026-06-15 15:23:00
Copyright for syndicated content belongs to the linked Source.